...
首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Strategies to minimize discomfort during diagnostic hysterosalpingography with disposable balloon catheters: a randomized placebo-controlled study with oral nonsteroidal premedication.
【24h】

Strategies to minimize discomfort during diagnostic hysterosalpingography with disposable balloon catheters: a randomized placebo-controlled study with oral nonsteroidal premedication.

机译:减少使用一次性球囊导管在子宫输卵管造影术中的不适感的策略:口服非甾体类药物的随机安慰剂对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess whether oral administration of 100 mg of nimesulide reduces pain during or after a hysterosalpingography (HSG) performed with disposable balloon catheters. DESIGN: Prospective, randomized, placebo-controlled study. SETTING: Reproductive Centre, Department of Obstetrics and Gynaecology, University of Genoa. PATIENT(S): Four hundred and forty patients undergoing HSG with a balloon catheter without applying a tenaculum. INTERVENTION(S): Patients were randomized to receive either 100 mg of oral nimesulide or a placebo solution 30 minutes before the HSG was performed. MAIN OUTCOME MEASURE(S): Patients recorded the degree of pain experienced during the examination, 2 hours afterward, and during the following week on a questionnaire using a 10-mm visual analogue scale (VAS). RESULT(S): Of the 331 (75.2 %) patients who returned the questionnaire, 151 had received nimesulide and 180 placebo. There was no difference in pain score between the two groups at any study point. Pain during HSG wascorrelated with nulliparity and tubal occlusion. Balloon inflation (cervix versus cavity) was not related to pain. CONCLUSION(S): Nimesulide does not reduce pain during or after HSG when the procedure is accomplished with a balloon catheter.
机译:目的:评估在一次性球囊导管进行子宫输卵管造影(HSG)期间或之后,口服100 mg尼美舒利是否可减轻疼痛。设计:前瞻性,随机,安慰剂对照研究。地点:热那亚大学妇产科生殖中心。患者:440例患者在不使用触角的情况下使用球囊导管进行HSG。干预:在进行HSG前30分钟,将患者随机分为100 mg口服尼美舒利或安慰剂溶液。主要观察指标:患者使用10毫米视觉模拟量表(VAS)在问卷中记录检查期间,术后2小时以及接下来一周的疼痛程度。结果:在331例(75.2%)返回问卷的患者中,有151例接受了尼美舒利和180例安慰剂。两组在任何研究点的疼痛评分均无差异。 HSG期间的疼痛与无节育和输卵管阻塞相关。球囊膨胀(子宫颈对腔)与疼痛无关。结论:使用球囊导管完成该程序时,尼美舒利不能减轻HSG期间或之后的疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号